SCHEMBL8724758

SCHEMBL8724758

CCC(NC(=O)c1cccnc1)C(=O)OC1CCCCC1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.48
CYP3A4 P08684 3/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
ALDH1A1 P00352 4/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
GPR132 Q9UNW8 2/20 0.45
CYP19A1 P11511 1/20 0.44
PREP P48147 1/20 0.44
FAP Q12884 1/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
KDM4E B2RXH2 1/20 0.44
LMNA P02545 1/20 0.43
NPC1 O15118 1/20 0.43
TP53 P04637 1/20 0.43
RAB9A P51151 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
ACACB O00763 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7663015 0.86 CTSL (0.50) CYP1A2ALDH1A1SMN1; SMN2KDM4ELMNA
Iodide SCHEMBL8726955 0.78 APOBEC3A (0.46) CYP1A2ALDH1A1SMN1; SMN2CYP19A1KDM4E
SCHEMBL19974885 0.78 ALDH1A1 (0.46) CYP1A2CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL8221634 0.77 GPR132 (0.64) CYP3A4CYP2C9CYP2C19ALDH1A1SMN1; SMN2
SCHEMBL9011205 0.76 LMNA (0.59) CYP3A4CYP2C9CYP2C19SMN1; SMN2GPR132
SCHEMBL7416164 0.74 HDAC1 (0.58) ALDH1A1SMN1; SMN2GPR132MEN1KMT2A
SCHEMBL9717131 0.74 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2KMT2ALMNANPSR1
SCHEMBL1106964 0.73 HDAC1 (0.62) CYP1A2CYP3A4ALDH1A1SMN1; SMN2MEN1
SCHEMBL24267375 0.72 ECE1 (0.60) ALDH1A1SMN1; SMN2MEN1KMT2AKDM4E
SCHEMBL29995369 0.72 ECE1 (0.60) ALDH1A1SMN1; SMN2MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0335545-B2 Pharmaceutical formulations for parenteral use UNIV FLORIDA (US) 1998-09-23 EP disclosed
EP-0327766-B1 Redox systems for brain-targeted drug delivery UNIV FLORIDA (US) 1998-04-08 EP disclosed
US-5525727-A ANALGESIC OR NARCOTIC ANTAGONIST UNIVERSITY OF FLORIDA (US) 1996-06-11 US disclosed
US-5187158-A Sustained delivery of viricides UNIVERSITY OF FLORIDA (US) 1993-02-16 US disclosed
US-5024998-A Administering in aqueous solution with cyclodextrin derivative UNIVERSITY OF FLORIDA (US) 1991-06-18 US disclosed
US-5017566-A Redox systems for brain-targeted drug delivery UNIVERSITY OF FLORIDA (US) 1991-05-21 US disclosed
US-5008257-A Penicillin or cephalosporin antibiotics UNIVERSITY OF FLORIDA (US) 1991-04-16 US disclosed
US-4983586-A Decreasing precipitation at injection site or in lungs or other organs by combining with hydroxypropyl-beta-cyclodextrin UNIVERSITY OF FLORIDA (US) 1991-01-08 US disclosed
US-4900837-A Brain-specific drug delivery of steroid sex hormones cleaved from pyridinium carboxylates and dihydro-pyridine carboxylate precursors UNIVERSITY OF FLORIDA (US) 1990-02-13 US disclosed
US-4880921-A Brain-specific drug delivery UNIVERSITY OF FLORIDA (US) 1989-11-14 US disclosed
EP-0335545-A2 Pharmaceutical formulations for parenteral use UNIVERSITY OF FLORIDA (US) 1989-10-04 EP disclosed
EP-0327766-A2 Redox systems for brain-targeted drug delivery UNIVERSITY OF FLORIDA (US) 1989-08-16 EP disclosed
US-4824850-A DIHYDROPYRIDINE-PYRIDINIUM SALT REDOX CARRIER UNIVERSITY OF FLORIDA (US) 1989-04-25 US disclosed